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ABSTRACT
Morinda elliptica has been used traditionally as a medicine to treat various diseases in Malaysia and 
Southeast Asia. In this present study, the cytotoxicity and immunomodulatory effects of damnacanthal 
and nordamnacanthal isolated from the roots of Morinda elliptica were studied. Cytotoxic study was 
performed on human leukemia cell lines (HL-60) and mouse myelomonocyte leukemia (Wehi-3B) cell 
line, whereas immunomodulatory effect was evaluated by using lymphocytes proliferation assay on 
mice thymocytes and human peripheral blood mononuclear cells (PBMC). The production of 
extracellular human interleukin-2 (IL-2) and human interleukin-12 (IL-12) were also assessed by using 
the enzyme-linked immunosorbent assay (ELISA). The results indicated that both damnacanthal and 
nordamnacanthal inhibited the proliferation of HL-60 cells with the IC50 of 4.0 µg/mL and 20 µg/mL, 
respectively, and were able to activate mice thymocytes and human peripheral blood mononuclear cells 
(PBMC) at low concentration (0.47 µg/mL). Moreover, the production of extracellular human 
interleukin-2 (IL-2) and human interleukin-12 (IL-12) from both compounds-activated PBMC were 
prominently upregulated after 24 hours and the concentration remained almost constant up to 72 
hours. Based on the results, both damnacanthal and nordamnacanthal can be cytotoxic and 
immunomodulatory agents which have the potential in cancer treatment.
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ABSTRAK
Morinda elliptica telah digunakan secara tradisional sebagai ubat untuk merawat pelbagai penyakit di 
Malaysia dan Asia Tenggara. Dalam kajian ini, kesan sitotoksik dan imunopemodulatan oleh 
damnacanthal dan nordamnacanthal yang dipencilkan dari akar Morinda elliptica telah dikaji. Kajian 
sitotoksik telah dijalankan pada sel jajar leukemia manusia (HL-60) dan sel myelomonosit leukemia 
mencit (Wehi-3B), manakala kesan pengawalaturan mononuklear darah periferi manusia (PBMC). 
Penghasilan interleukin-2 (IL-2) dan interleukin-12 (IL-12) ekstrasel manusia telah juga dinilai dengan 
menggunakan asai penjerapan imun-berangkai-enzim (ELISA). Keputusan menunjukkan bahawa 
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kedua-dua damnacanthal dan nordamnacanthal menyekat penggandaan sel HL-60 dengan IC50 4.0 µg/mL dan 20 µg/mL masing-masing, dan dapat mengaktifkan timosit mencit dan PBMC pada 
kepekatan rendah (0.47 µg/mL). Di samping itu, penghasilan IL-2 dan IL-12 ekstrasel manusia dari 
PBMC yang diaktifkan oleh kedua sebatian telah dengan jelasnya meningkat selepas 24 jam dan 
kepekatan kekal malar sehingga 72 jam. Berdasarkan kepada keputusan ini, kedua-dua damnacanthal 
dan nordamnacanthal boleh menjadi agen sitotoksik dan imunopemodulatan yang mempunyai potensi 
dalam rawatan barah.
Kata kunci: Morinda elliptica, damnacanthal, nordamnacanthal, imunomodulatan, sitotoksisiti
______________________________________________________________________________
INTRODUCTION
Morinda species are the most popular herbs worldwide. One of these species is Morinda elliptica which 
is widely distributed in Peninsular Malaysia. This herb has been used traditionally as a medicine to treat 
various diseases such as headache, cholera, diarrhea, gastritis and fever (Ong and Norzalina, 1999). In 
Malaysia, the pounded leaves of this herb were commonly added to rice for people who have loss of 
appetite (Jasril et al., 2003). In addition, this herb is also claimed by local people to stimulate the 
immune system and thus prevent the formation and proliferation of cancers including the malignant 
ones. 
Morinda elliptica has long been known to contain a substantial amount of anthraquinones such as 
damnacanthal and nordamnacanthal. Both damnacanthal and nordamnacanthal have some unique 
chemical and biological properties. It was reported that damnacanthal isolated from noni roots acted 
as an inhibitor of ras function, which is believed to be associated with the signal transduction in several 
human cancers such as lungs, colon and leukemia (Hiramatsu et al., 1993). Damnacanthal has been 
shown to have a potent inhibitory activity towards tyrosine kinase such as Lck, Scr, Lyn and EGF 
receptors (Hiwasa et al., 1999). Furthermore, damnacanthal which is solubilized in DMSO also affects 
intracellular Ca2+ mobilization as demonstrated in cultured bovine coronary endothelial cells (Aoki et 
al., 2000) and showed an intense inhibitory effect against DNA topoisomerase 11 with an IC50 of 20 
µg/mL (Tosa et al., 1998). 
It was demonstrated that damnacanthal and nordamnacanthal isolated from Morinda elliptica were 
cytotoxic towards MCF-7 (breast carcinoma) and CEM-SS (T-lymphoblastic leukemia) cell lines. Both 
compounds were also found to have strong antimicrobial activity while only damnacanthal showed 
moderate activity against HIV (Ali et al., 2000). More recently, Masakazu et al. (2006) discovered that 
damnacanthal possesses as an inhibitor of viral protein R (Vpr) which is important in the development 
of anti-HIV therapy. 
Undoubtedly, both compounds exhibited various pharmacological activities. However, no 
specific study has been reported on the immunomodulatory activity of damnacanthal and 
nordamnacanthal in mice and human immune cells. In this study, the immunomodulatory and 
cytotoxic activities of both compounds were evaluated.
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MATERIALS AND METHODS
Materials
Damnacanthal and nordamnacanthal isolated from the roots of Morinda elliptica were kindly supplied 
by Professor Dr. Md. Nordin Hj. Lajis, from the Laboratory of Natural Products, Institute of 
Biosciences, Universiti Putra Malaysia. The concentrated compounds were dissolved in 
dimethylsulphoxide (DMSO) (Sigma, USA) to get a stock solution of 10  mg/mL. The substock 
solution of 0.06 mg/mL was prepared by diluting 6 μL of the stock solution into 994 μL serum-free 
culture medium, RPMI 1640 (Sigma, USA) (the percentage of DMSO in the experiment should not 
exceed 0.5). The stock and substock solutions were both stored at 4 °C.
Concanavalin A (Con A) (Sigma, USA), lipopolysaccharide (LPS) (from Salmonella enteritidis) 
(Sigma, USA) and Pokeweed mitogen (PWM) (1  mg/mL) were used as a positive control. This 
commercial immunomodulator was prepared by dissolving it with RPMI 1640 (Sigma, USA). The 
stock and substock solutions were prepared as above. 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), RPMI 1640, phosphate 
buffered saline (PBS), Dulbecco’s Modified Eagle Medium (DMEM), 2-mercaptoethanol, 
6-mercaptopurine and dimethyl sulphoxide (DMSO) were all purchased from Sigma. Foetal bovine 
serum (FBS) from PAA, IL 2 and IL 12 Instant Enzyme Link Immunosorbent Assay (ELISA) kit was 
purchased from Bender MedSystems, Austria, and Ficoll-Paque Plus was purchased from Amersham 
Biosciences. 
Preparation of Mice Thymus Cell Suspensions
ICR mice, 5-8 weeks old, were used in all experiments. The animals were purchased from Animal 
House, Universiti Putra Malaysia. The animals were housed under standard conditions at 25 ± 2 °C 
and fed with standard pellets and tap water. The mice were protected from stress or specific control. 
This work has been approved by the Animal Care and Use Committee, Universiti Putra Malaysia 
(UPM), (Ref: UPM/ FPV/ PS/ 3.2.1.551/ AUP-R2).
The mice were killed by cervical dislocation. The thymus which is located above the heart, was 
removed and quickly washed with Hank’s Balanced Salts Solution (HBSS) in a petri dish. The thymus 
was minced and pressed through a sterile wire mesh screen with a rubber syringe plunger. The cell 
suspension was washed with PBS supplemented with 0.1% (w/v) BSA and 0.06% (w/v) sodium 
citrate (PBS-BSA-SC) and spun down at 200 x g for 10 minutes. The step was repeated until the pellet 
was clean as shown by absence of any debris or contaminant. The supernatant was discarded, and 4 
mL of Dulbecco’s Modified Eagle Medium (DMEM) with 10% (v/v) heat inactivated serum was 
added. The pellet was resuspended and cell counting was performed, to determine the lymphocyte cell 
number in the suspension. All of the above steps were carried out under sterile conditions in a 
biological safety cabinet to prevent any contamination.
Isolation of Peripheral Blood Mononuclear Cells (PBMC)
Venous blood (20-25 mL) was collected aseptically from 20 healthy donors in preservative free heparin 
tubes. The blood was diluted with phosphate buffered saline (PBS) pH 7.4, and layered onto Ficoll 
plus at the ratio of diluted blood with Ficoll 2:1 (Amersham). After centrifugation at 400 x g for 50 
minutes, the lymphocytes were collected at the interface and washed three times with the PBS. The 
cells were resuspended in DMEM with 10% (v/v) foetal bovine serum and antibiotics.
31
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Cell Line
The cell lines used were human promyelocytic leukemia (HL-60) and mouse embryo fibroblast (3T3). 
HL-60 was obtained from RIKEN Cell Bank, Tsukuba, Japan and 3T3 was obtained from the 
American Type Culture Collection ATCC (Rockville, MD). The cells were grown and maintained in 
RPMI 1640 (Sigma, USA) medium; supplemented with 10% (v/v) fetal bovine serum (Flow 
Laboratory, Australia), 100 IU/mL penicillin (Flow Laboratory, Australia) and 100 g/mL 
streptomycin (Flow Laboratory, Australia) at 37 °C, 5% CO2 and 90% humidity.
MTT Cell Viability Assay
The effects of both compounds on cell viability of mice thymocytes, human PBMC, HL-60, Wehi-3B 
and NIH 3T3 were first determined by using a colorimetric technique, which is 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay (Mosmann, 1983). Briefly, 
100 μL of DMEM/RPMI 1640 media with 10% (v/v) of FBS was added into all the wells except row 
A in the 96-well plate (TPP, Switzerland). Then, 100 μL of diluted compounds at 60 μg/mL was added 
into row A and row B. A series of twofold dilution of compound was carried out down from row B 
until row G. The row H was left untouched and the excess solution (100 μL) was discarded, then 100 
μL of cells (mice thymocytes, human PBMC, HL-60, Wehi-3B or NIH 3T3) with cell concentration at 
4 × 105 cells/mL was added into all wells in the 96-well plate and incubated at 37 °C, 5% CO2 and 90% 
humidity for 72 h. After the incubation period, 20 μL of MTT (Sigma, USA) at 5 mg/mL was added 
into each well in the 96-well plate and incubated for 4 h at 37 °C, 5% CO2 and 90% humidity. One 
hundred and seventy microlitres of medium with MTT was removed from every well and 100 μL 
DMSO (Sigma, USA) was added to each well to compound and solubilize the formazan crystal by 
incubating for 20 min at 37 °C, 5% CO2 incubator. Finally, the plate was read at 570 nm and reference 
wavelength at 630 nm by using μ Quant ELISA Reader (Bio-Tek Instruments, USA). The results of 
the compounds were compared with the result of ConA (1  μg/mL) and LPS (1  μg/mL) for 
immunomodulation, while Doxorubicin (Sigma, USA) for cytotoxicity, and without mitogens/drug or 
compounds by using the same method. Each compound and control was assayed in triplicate or three 
times. The cytotoxic dose that kills cells by 50% (IC50) was determined from absorbance (OD) versus 
concentration curve, and the percentage of proliferation was calculated by the following formula:
Percentage (%) of cell proliferation = OD sample X 100
                                                                 OD control
Cytokine Production of Human Peripheral Blood Mononuclear Cells
The expressions of extracellular IL-2 and IL-12 were performed by using Cytokine Instant Enzyme 
Link Immunosorbent Assay (ELISA) kit (Bender MedSystems, Austria). Briefly, the extracted human 
PBMC with cell concentration at 5 x 105 cells/mL was treated with the same volume of compounds at 
30 μg/mL in 6 well culture plates (TPP, Switzerland). Control cultures without compound and 
positive control with Pokeweed Mitogen (50 µg/mL) were prepared simultaneously. The culture was 
then incubated for respective times (24 hours, 48 hours, and 72 hours). After the corresponding 
period, the samples were harvested and pelleted. 50 µL of the supernatant was added onto the strip on 
the plate of the kit and incubated for 3 hours with 200 rpm shaking. Then, the samples were washed, 
followed by immediate addition of 3,3',5,5''-tetramethylbenzidine (TMB) peroxidase substrate in the 
dark. Finally, 1M phosphoric acid stop solution was added and the plate was read at 450 nm, and 620 
nm as a reference wavelength, by using µ Quant ELISA Reader (Bio-Tek Instruments, USA) at the 
Animal Tissue Culture Laboratory, Faculty of Biotechnology and Biomolecular Sciences, UPM. The 
result was compared to the control strip in the kit. Each compound and control was assayed three 
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times. Data were expressed as pg/mL. 
Statistical Analysis
All experiments were performed in triplicate and the results were expressed as mean ± standard error. 
RESULTS
Cytotoxicity Effect of Damnacanthal and Nordamnacanthal on Leukemia Cell Lines and 
Normal Cell
Damnacanthal was found to inhibit both leukemia cell lines tested, HL-60 and Wehi-3B, respectively, 
with the IC50 value less than 5 µg/mL after 72 h of treatment (Table 1). Moreover, it did not inhibit 
normal cell 3T3. In contrast, nordamnacanthal only showed a weak toxicity effect towards HL-60 with 
the IC50 value of 23 µg/mL, and it had no effect towards Wehi-3B and 3T3. Doxorubicin exhibited 
stronger inhibition towards both leukemia cell lines with the IC50 value less than 3 µg/mL, but also 
exhibited a toxicity effect towards normal cell 3T3 with the IC50 value of 3 µg/mL. 
Table 1. Effects of damnacanthal, nordamnacanthal and doxorubicin towards HL-60, Wehi-3B and 
NIH 3T3 cell lines after 72 hours of treatment.
Mitogenic Activity of Damnacanthal and Nordamnacanthal on Mice Thymocytes
Both compounds were found to significantly stimulate the proliferation of mice thymocytes in a dose- 
and time-dependent fashion (Figures 1 and 2). Damnacanthal exhibited significantly higher 
proliferation of mice thymocytes as compared to the control group after 24 h, but the proliferation 
reduced drastically after 48 h and 72 h of incubation. Maximal growth was found after 24 h of 
incubation with 30 µg/mL of the compound, achieving a 2.1 fold higher than the positive control, Con 
A. Con A is a lectin protein originally extracted from jack bean (Canavalia ensiformis), which was used as 
a positive control in evaluating mice thymocytes since this mitogen was known to induce T cells (Ho 
et al., 2004). It was used at its optimal concentration (2.5 µg/mL), and was found to prominently 
promote the lymphocyte growth in a time-dependent fashion with maximal growth after 24 h 
treatment. However, this proliferation decreased significantly after 48 h and 72 h with values of 
66.12% and 28.86%, respectively. 
Cell 
lines  
Compounds  
IC50 value (µg/mL)   
HL -60 Wehi-3B 3T3 
Damnacanthal  
Nordamnacanthal  
Doxorubicin  
4.2 ± 0.1  
23.3 ± 0.7  
1.2 ± 0.1  
3.3 ± 0.5  
> 30  
1.0 ± 0.9  
> 30  
> 30  
3.0 ± 0.8  
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In addition, nordamnacanthal also stimulated proliferation of mice thymocytes after 24 h 
treatment (Figure 2). It significantly stimulated higher proliferation of mice thymocytes up to 132.02% 
at a concentration of 30 µg/mL after 24 h treatment, achieving 1.5-fold higher as compared to Con A. 
The proliferation rate of mice thymocytes treated with nordamnacanthal was drastically decreased 
after 48 h and slightly increased after 72 h treatment, at all concentrations tested. The pattern of 
proliferation of mice thymocytes by both compounds seemed to be quite similar. Both compounds 
were not toxic to mice thymocytes even at a higher concentration of 30.0 µg/mL. Furthermore, it 
clearly showed that damnacanthal exhibited better proliferation of mice thymocytes than 
nordamnacanthal and Con A. 
Mitogenic Activity of Damnacanthal and Nordamnacanthal on Human Peripheral Blood 
Mononuclear Cells (PBMC)
Both damnacanthal and nordamnacanthal were found to stimulate the proliferation of PBMC in a 
dose- and time-dependent manner (Figures 3 and 4). Damnacanthal induced the highest proliferation 
of PBMC at 24 h treatment with a value of 46.6% at a concentration of 30.0 µg/mL. At this incubation 
time, it significantly showed better proliferation of PBMC compared to PWM.
Fig. 1. Mitogenic activity of damnacanthal on mice thymocytes using MTT assay. Mice thymocytes 
were isolated and incubated with increasing concentrations (0.47-30.0 µg/mL) of damnacanthal or 
Con A (2.5 µg/mL, as positive control) in culture medium for 24 h, 48 h and 72 h (P < 0.05). Results 
were expressed as mean % ratio of MTT absorbance in damnacanthal treated and control well ± 
standard error of three independent experiments with three wells each.
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Fig. 2. Mitogenic activity of nordamnacanthal on mice thymocytes using MTT assay. Mice 
thymocytes were isolated and incubated with increasing concentrations (0.47-30.0 µg/mL) of 
nordamnacanthal or Con A (2.5 µg/mL, as positive control) in culture medium for 24 h, 48 h and 72 
h (P < 0.05). Results were expressed as mean % ratio of MTT absorbance in nordamnacanthal 
treated and control well ± standard error of three independent experiments with three wells each.
Fig. 3. Mitogenic acitivity of damnacanthal on human PBMC using MTT assay. PBMC was isolated 
and incubated with increasing concentrations (0.47-30.0 µg/mL) of damnacanthal or PWM (50.0 
µg/mL, as positive control) in culture medium for 24 h, 48 h and 72 h (P < 0.05). Results were 
expressed as mean % ratio of MTT absorbance in nordamnacanthal treated and control well ± 
standard error of three independent experiments with three wells each.
Similar to damnacanthal, nordamnacanthal has significantly exhibited the highest proliferation of 
PBMC at 24 h treatment; up to 43.1% at a concentration of 30.0 µg/mL. However, the proliferation 
response induced by nordamnacanthal was less than that of PWM after 48 h and 72 h treatments. 
Obviously, damnacanthal and nordamnacanthal seemed to stimulate effective PBMC at early 
incubation hours (24 h) whereas PWM seemed to stimulate effective PBMC at longer incubation 
hours.
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Fig. 4. Mitogenic acitivity of nordamnacanthal on PBMC using MTT assay. PBMC was isolated and 
incubated with increasing concentrations (0.47-30.0 µg/mL) of nordamnacanthal or PWM (50 
µg/mL, as positive control) in culture medium for 24 h, 48 h and 72 h (P < 0.05). Results were 
expressed as mean % ratio of MTT absorbance in nordamnacanthal treated and control well ± 
standard error of three independent experiments with three wells each.
The Production Extracellular Human IL-2 and Human IL-12
As shown in Figure 5, damnacanthal and nordamnacanthal had significantly induced the production 
of human extracellular IL-2 in a time-dependent manner. Interestingly, both compounds, 
damnacanthal and nordamnacanthal, have promoted a higher induction of human IL-2 after 24 h of 
incubation with values of 151.7 pg/mL and 267.0 pg/mL, respectively; compared to the negative 
control with a value of 20 pg/mL. However, the concentration of IL-2 decreased significantly after 48 
h and 72 h of damnacanthal treatment, with the reduction to only 6.8 and 1.8 fold higher than the 
negative control, respectively. Nordamnacanthal has significantly induced higher production of 
human IL-2 after 24 h treatment with 13.3-fold higher compared to the negative control. Similar to 
damnacanthal, it also reduced the production of human IL-2 after 48 h and 72 h treatments with 
2.7-fold and 1.5-fold of negative control, respectively. In contrast, the production of human IL-2 
induced by PWM increased in a time dependent manner, which showed a much higher production of 
human IL-2 after 48 h of incubation, 25.3-fold higher compared to the negative control. In addition, 
it also demonstrated a steady induction of human IL-2 throughout the treatment period. 
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Fig. 5. The production of human IL-2 in culture supernatants upon stimulation of PBMC by 
damnacanthal, nordamnacanthal and PWM. PBMC was isolated and incubated at 24 h, 48 h and 72 h 
with active concentrations (damnacanthal and nordamnacanthal at 30.0 µg/mL) and (PWM at 50.0 
µg/mL), and IL-2 induction was specifically determined by ELISA. Values were the means ± 
standard error of three experiments (P < 0.05).
As shown in Figure 6, the production of human IL-12 by damnacanthal and nordamnacanthal 
was higher than that of the negative control, which produced 12 pg/mL of IL-12. There was no 
significant difference in the concentration of extracellular IL-12 induced by the treatment of 
damnacanthal on PBMC after 24 h and 72 h of treatment where the values were 61.3 pg/mL and 59.0 
pg/mL, respectively (P > 0.05). Results indicated that it had significantly induced the production of 
human IL-12 at 24 h and 72 h treatments with 5.1 and 4.9-fold higher compared to the negative 
control, respectively. Damnacanthal obviously exhibited a sharp reduction in the production of human 
IL-12 after 48 h of treatment with a value of only 1.1-fold higher compared to the control. 
Interestingly, nordamnacanthal also induced a rather similar amount of human IL-12 after 24 h and 72 
h, with the values of 48.0 and 52.0 pg/mL, respectively. Moreover, both compounds exhibited a sharp 
reduction in the production of human IL-12 after 48 h treatment with 13.3 pg/mL by damnacanthal, 
and 13.0 pg/mL by nordamnacanthal, respectively, or 1.1 and 1-fold higher compared to the control. 
This might be due to the fact that both compounds were derived from the same group of 
anthraquinones.
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Fig. 6. The production of human IL-12 in culture supernatants upon stimulation of PBMC by 
damnacanthal and nordamnacanthal.  PBMC was isolated and incubated at 24 h, 48 h and 72 h with 
active concentrations of damnacanthal and nordamnacanthal at 30 µg/mL and IL-2 induction was 
specifically determined by ELISA. Values were the means ± standard error of three experiments (P 
< 0.05).
DISCUSSION
Damnacanthal and nordamnacanthal are anthraquinones that are produced mainly by plants of the 
Rubiaceae family. Both compounds were commonly isolated from Morinda citrifolia, Morinda elliptica, 
Morinda lucida, Prismatomeris fragrans and others (Ismail et al., 1997; Tosa et al., 1998; Kwanjai et al., 2004). 
In this present study, both compounds were shown to possess cytotoxic effects towards several 
leukemia cell lines with IC50 value of less than 10 µg/mL after 72 hours of treatment. 
Apparently, both compounds showed a toxicity effect towards leukemia cell lines which are 
categorized as anchorage-independent cell lines. Previously, Ali et al. (2000) reported that both 
damnacanthal and nordamnacanthal compounds exhibited more sensitivity towards the 
anchorage-independent cell lines. This is due to the fact that the anchorage-dependent cell lines require 
attachment to a solid matrix in order to proliferate, thus making them interact with each other through 
cell to cell contact and generate transmembrane signals that not only affected the cell proliferation, 
migration and differentiation, but also the survival of the cell that prevents it from undergoing 
apoptosis. Therefore, damnacanthal and nordamnacanthal have been shown to be toxic towards the 
anchorage-independent cells, particularly on leukemia cell lines groups that are grown in suspension 
culture. 
 Even though the chemical structure between damnacanthal and nordamnacanthal is closely 
related (Figure 7), there was a significant difference on the cytotoxicity effect towards several cell lines 
due to the existence of methoxyl group (-OCH3) of damnacanthal at position C-1 whilst 
nordamnacanthal has hydroxyl group (-OH) at the same position. The existence of this different group 
was predicted to be the contributing factor to the variable effects of damnacanthal and 
nordamnacanthal towards cancerous cell lines. According to Ali et al. (2000), the presence of hydroxyl 
group at C-1 and C-3 and/or a formyl group at C-2 in the anthraquinone skeleton, such as 
nordamnacanthal and rubiacin may exert their cytotoxicity effects towards several cancerous cell lines. 
Nevertheless, Kamei et al. (1998) reported that anthraquinones with more hydroxyl groups were more 
effective than those with less or without the existence of the group. Konoshima et al. (1989) discovered 
that not only the number but the position of hydroxyl groups would also influence the activity of an 
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anthraquinone.
        
                                
  
  Damnacanthal                              Nordamnacanthal
Fig. 7. The chemical structures of damnacanthal and nordamnacanthal.
Since damnacanthal and nordamnacanthal were known to possess some unique chemical and 
biological properties, the cytotoxicity effects of both compounds towards several cell lines appeared to 
be extremely variable. Recently, Kwanjai et al. (2005) demonstrated that damnacanthal and 
nordamnacanthal isolated from Prismatomeris fragrans were cytotoxic towards human small cell lung 
cancer (NCI-H187) and human breast cancer (BC) cell lines. This result is similar with the previous 
results obtained by Ali et al. (2000) that showed damnacanthal was cytotoxic towards breast carcinoma 
cells (MCF-7). Besides, Jasril et al., (2003) reported that nordamnacanthal exhibited strong antitumor 
promoting activity towards Epstein Barr Virus activation in Raji cells. According to Shier et al. (1991), 
purified compounds that require concentration of less than 10 µg/mL to exhibit their cytotoxicity are 
considered as promising cancer chemotherapy agents. Hence, it seems likely that both damnacanthal 
and nordamnacanthal have good potential to be developed into new cancer chemotherapy agents.
Immunomodulatory studies revealed that both compounds significantly enhanced the mice 
thymocytes and PBMC proliferation, as compared to the control group, without causing inhibition at 
all concentrations tested. This result was in agreement with the results published by Wang et al. (2002), 
where the thymus in animals treated with the juice extract isolated from Morinda citrifolia was enlarged. 
The chemical constituents contained in the Morinda citrifolia including damnacanthal and 
nordamnacanthal may have enhanced immune function by stimulating thymus growth and thus 
exhibited anti-ageing and anti-cancer activities. Previously, Hirazumi and co-workers (1996) reported 
that the juice extracted from Morinda citrifolia was found to inhibit Lewis lung tumors in mice (LLC) 
which was associated with the stimulation of T cell immune response and thymocytes proliferation. 
Besides, mice with injected LLC ingested a daily dose of 15.0 mg of noni juice had a significant increase 
(119%) in life span (Hirazumi et al., 1996; Hirazumi and Furusawa, 1999). In addition, the ingestion of 
noni combined with conventional chemotherapy in the treatment of mice with cancer, proved to 
increase life span (Hirazumi et al., 1994). Hence, those finding did support the capability of both 
damnacanthal and nordamnacanthal compounds in enhancing the immune system through 
modulation of thymus proliferation and regeneration.
Moreover, damnacanthal and nordamnacanthal are also included in the group of phenolic 
compounds. Phenolic compounds have been known to possess broad biological activities, including 
as an immune enhancer (Maria et al., 2006). According to Zhao et al. (2007), previous studies have 
indicated that many phenolic compounds could stimulate the proliferation of splenocytes. The most 
common phenolic compound known to have immunomodulator activities is scopoletin (Wang and Su, 
2001; Maria et al., 2006). The phenolic compounds could stimulate or suppress the immune system due 
to the hydroxyl groups in their structure. The hydroxyl groups can affect the enzyme or 
electron-transferring system, thus resulting in immunomodulating property, particularly in 
proliferation of lymphocytes and phagocytosis (Manosroi et al., 2003). 
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IL-2 and IL-12 play an important role in regulating the proliferation, differentiation and cytolytic 
activity of lymphocytes. Thus, the modulatory effects of damnacanthal and nordamnacanthal on the 
production of these cytokines were studied. Damnacanthal and nordamnacanthal were found to 
induce higher production of human IL-2 than that of human IL-12 in a time-dependent manner. 
PWM was used as a positive control since it had been reported previously to induce IL-2 and IFN-γ 
production (Stanilova et al., 2005). The present result showed that the induction of human IL-2 by 
damnacanthal and nordamnacanthal were less than that of PWM throughout the treatment periods, 
but was higher if compared to their capability to induce the production of human IL-12. IL-2 
expression is dependent on T cell activation (Adam et al., 2003). Thus, this finding suggests that both 
compounds tend to induce T cell compared to B cell, since IL-2 is known as a central cytokine in the 
regulation of T cell responses (Meena and Donna, 2004). In addition, the population of T and B 
lymphocytes, in human peripheral blood lymphocytes, in which 90% is T cell while only 10% is B cell 
(Cerqueira et al., 2004), may contribute to a higher production of human IL-2 in culture supernatant 
treated with damnacanthal and nordamnacanthal.
Subsequently, it is interesting that damnacanthal and nordamnacanthal were shown to modulate 
normal lymphocytes (peripheral blood mononuclear cells), induced human IL-2 production and at the 
same time it was cytotoxic towards CEM-SS cells which originated from T-lymphoblastic cells. The 
capability of damnacanthal and nordamnacanthal in stimulating the proliferation of T cells and 
inducing the production of human IL-2 could play a very important role in the killing and suppression 
of cancer cells. The induction of IL-2 could play an essential role in triggering NK cell population, a 
heterogenous group of granular lymphocytes that appear very effective in lysing target cancer cells 
through activation of lymphokine activated killer cells (LAK) (Maria et al., 2006). Moreover, tumor 
cells of various types possess unique sets of tumor markers that can be recognized by NK cells (Farag 
and Caliguiri, 2006). In addition, the lytic process by NK cells involved the release of cytotoxic factors 
for which there seem to be more receptors on the surface of target cancer cells than on malignant self 
cells. Therefore, this finding suggests that damnacanthal and nordamnacanthal could be developed as 
a new anticancer chemotherapy agent particularly in treating leukemic cells originated from 
T-lymphocytes cells, without causing the cytotoxic effect towards normal cells. 
CONCLUSION
This study suggests that damnacanthal and nordamnacanthal have a huge potential in combating 
cancer cells without or with less toxicity effect towards healthy cells, and at the same time might 
enhance the immune system. However, further studies are needed to elucidate the exact mechanism of 
action involved in both compounds.
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